A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Cohen SJ; Zalupski MM; Modiano MR; Conkling P; Patt YZ; Davis P; Dorr RT; Boytim ML; Hersh EM; Cancer Chemotherapy And Pharmacology, 2010, vol. 66, issue 2, p 287, ISSN 14320843. ISBN 14320843.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef